cardiac rehab, cardiac rehabilitation, CHF, heart failure

Congestive heart failure patient Dorothy Moore committed herself to cardiac rehabilitation and increasing the amount of exercise she did and was able to reverse her heart failure class. Patient engagement is key to improving CHF patient quality of life and outcomes without the use of drugs and devices.

Feature | Cardiac Rehabilitation | May 24, 2016 | Karen D. Walker, RN, MSN, and Stephanie Rejc, MS
Cardiac rehabilitation and exercise training has been shown to improve clinical status and outcomes in congestive heart...
HeartFlow, FFR-CT, ruptured coronary plaques, EMERALD study, EuroPCR 2016
News | CT Angiography (CTA) | May 23, 2016
May 23, 2016 — First-in-human data presented at EuroPCR 2016 demonstrate that hemodynamic data from HeartFlow Inc. may...
Boston Scientific, FDA, IntelliNav XP ablation catheters, Rhythmia Mapping System

Rhythmia Mapping System image courtesy of Boston Scientific

Technology | Ablation Systems | May 23, 2016
May 23, 2016 — Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for two catheters that...
Mitralign, Series E funding, Trialign, MPAS
News | Heart Valve Technology | May 23, 2016
May 23, 2016 — Mitralign Inc. announced it has raised $39.8 million to date in a Series E equity round of financing....
News | Heart Failure | May 23, 2016
May 23, 2016 — In a guideline update published last week, the American College of Cardiology, American Heart...
TAVR outcomes, aortic valve gradient, JACC study
News | Heart Valve Technology | May 23, 2016
May 23, 2016 — Patients with a combination of left ventricular dysfunction and low aortic valve gradient have higher...
Direct Flow Medical, TAVR device, DISCOVER trial, three-year results, EuroPCR 2016
News | Heart Valve Technology | May 20, 2016
May 20, 2016 — Direct Flow Medical Inc. presented three-year results from its prospective, multicenter DISCOVER Trial...
PCI, OFDI, OCT, optical coherence tomography, optimal frequency domain imaging, EuroPCR 2016 study
News | Intravascular Imaging | May 20, 2016
May 20, 2016 — Using optimal frequency domain imaging (OFDI) to guide...
Watchman, left atrial appendage closure, LAA occluder, LAA. LAAO, laa occluder, left atrial appendage, Watchman

The Boston Scientific Watchman device is currently the only transcatheter LAA occluder cleared for use in the United States.

Feature | Left Atrial Appendage (LAA) Occluders | May 20, 2016 | Dave Fornell
Atrial fibrillation (AF) affects nearly 6 million Americans and the condition puts them at significantly greater risk...
News | Atrial Fibrillation | May 19, 2016
May 19, 2016 — Physician-researchers in the College of Medicine at the University of Cincinnati have developed a...
Bioventrix, Revivent-TC System, heart failure, first-in-man procedure
News | Heart Failure | May 19, 2016
May 19, 2016 — BioVentrix announced the first-in-man use of its next-generation Revivent-TC System with an endovascular...
St. Jude Medical, EuroPCR 2016 studies, FFR, LAAO, left atrial appendage occlusion, fractional flow reserve, Amplatzer
News | Cath Lab | May 19, 2016
May 19, 2016 — St. Jude Medical Inc. announced results from two cardiovascular clinical trials presented at EuroPCR...
clot, coronary thrombus, antiplatelet therapt, DAPT

An intravascular ultrasound (IVUS) image of a thrombus formed in a coronary artery.  While there are guidelines for antiplatelet therapy, there are still questions over the duration of such therapy. 

Feature | Antiplatelet and Anticoagulation Therapies | May 19, 2016 | Marianne Pop, Pharm.D., BCPS
There are many opinions on the duration of dual antiplatelet therapy (DAPT), highlighted at the 2016 American College...
bioabsorbable vascular graft, children, feasibility study, Bakoulev Center Moscow, AATS 2016 meeting

Image courtesy of Bakoulev Scientific Center for Cardiovascular Surgery

News | Stent Grafts | May 18, 2016
May 18, 2016 — Bioabsorbable heart valves or blood vessels are designed to harness the body’s innate healing process,...
Overlay Init